N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer-Reference-Cited by-同舟云学术

N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer

Published:2023-04 Issue:4 Volume:4 Page:101002
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Auf der Maur Priska^ORCID,Trefny Marcel P.,Baumann Zora,Vulin Milica,Correia Ana Luisa,Diepenbruck Maren,Kramer Nicolas,Volkmann Katrin,Preca Bogdan-Tiberius,Ramos Pedro,Leroy Cedric,Eichlisberger Tobias,Buczak Katarzyna,Zilli Federica,Okamoto Ryoko,Rad Roland,Jensen Michael Rugaard,Fritsch Christine,Zippelius Alfred,Stadler Michael B.,Bentires-Alj Mohamed^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference96 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA. Cancer J. Clin.,2021

2. Emerging strategies for treating metastasis;Esposito;Nat. Cancer,2021

3. Feed-forward loops between metastatic cancer cells and their microenvironment—the stage of escalation;Baumann;EMBO Mol. Med.,2022

4. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance;Ramos;Oncogene,2015

5. Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer;Miller;Breast Cancer Res.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S-(N,N-diethyldithiocarbamoyl)-N-acetyl- l -cysteine for the treatment of non-small cell lung cancer through regulating NF-κB signalling pathway without neurotoxicity;Journal of Drug Targeting;2024-07-12

2. A disulfiram derivative against lung cancer via the Notch signaling pathway without neurotoxicity and hepatotoxicity;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-26

3. Breast cancer risk inNF1-deleted patients;Journal of Medical Genetics;2023-12-22

4. Exploiting metabolic vulnerabilities in breast cancers with NF1 loss;Cell Reports Medicine;2023-04